Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
mark jonh
… England Journal of …, 2006
View PDFchevron_right
Addition of Rosiglitazone to Glimepirid and Metformin Combination Therapy in Type 2 Diabetes
Mehmet Sargin
Endocrine Journal, 2004
View PDFchevron_right
Triple Therapy in Type 2 Diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients
Poul Strange
Diabetes Care, 2006
View PDFchevron_right
Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet
Philip Raskin
Diabetes, Obesity and Metabolism, 2009
View PDFchevron_right
Rosiglitazone in Combination With Glimepiride Plus Metformin in Type 2 Diabetic Patients
Gennie Vlachou
Diabetes Care, 2002
View PDFchevron_right
Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes
Juan Barbosa
Diabetes-metabolism Research and Reviews, 2002
View PDFchevron_right
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial
Arrigo Cicero
Diabetes, Obesity and Metabolism, 2006
View PDFchevron_right
A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients
Alessandro Coppini
Acta Diabetologica, 1999
View PDFchevron_right
Effects of Rosiglitazone, Glyburide, and Metformin on -Cell Function and Insulin Sensitivity in ADOPT
B. Zinman
Diabetes, 2011
View PDFchevron_right
A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type 2 Diabetes
Paresh Dandona
Diabetes Care, 2002
View PDFchevron_right
Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes
Lucio Vilar
Arquivos Brasileiros de Endocrinologia & Metabologia, 2010
View PDFchevron_right
Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes
Luc Van Gaal
Diabetes, Obesity and Metabolism, 2003
View PDFchevron_right
An open level study to assess the glycemic control effect of metformin and Pioglitazone as add on therapy along with sulfonylurea in uncomplicated type2 …
goutameswar mazumdar
Journal of Diabetes Mellitus, 2012
View PDFchevron_right
Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy
Barbara Kravitz
Clinical Journal of the American Society of Nephrology, 2011
View PDFchevron_right
Metabolic effects of rosiglitazone and metformin in Greek patients with recently diagnosed type 2 diabetes
Dimitrios Karamitsos
In vivo (Athens, Greece)
View PDFchevron_right
An open level study to assess the glycemic control effect of metformin and Pioglitazone as add on therapy along with sulfonylurea in uncomplicated type2 diabetes mellitus
Anindya Dasgupta
Journal of Diabetes Mellitus, 2012
View PDFchevron_right
Glycemic Control in Type 2 Diabetes (Drug Treatments)
Floris Laar
View PDFchevron_right
COMPARATIVE STUDY TO EVALUATE EFFICACY AND SAFETY OF PIOGLITAZONE VERSUS VOGLIBOSE ON GLYCEMIC PARAMETERS IN PREDIABETES PATIENTS ADD ON METFORMIN
Dr Mohd F A H E E M Mubeen
View PDFchevron_right
Induction of long-term glycemic control in type 2 diabetic patients using pioglitazone and metformin combination
Vijay Panikar
The Journal of the Association of Physicians of India, 2007
View PDFchevron_right
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
Byron Hoogwerf
The Lancet, 2006
View PDFchevron_right
Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy
Julius Vaz
Clinical Therapeutics, 2003
View PDFchevron_right
Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation
Frank Lauster
Clinical Therapeutics, 2003
View PDFchevron_right
Rosiglitazone Therapy Improves Insulin Resistance Parameters in Overweight and Obese Diabetic Patients Intolerant To Metformin
Arrigo Cicero
Archives of Medical Research, 2008
View PDFchevron_right
Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes
Philip Raskin
Diabetologia, 2000
View PDFchevron_right
Efficacy of Some Combination Regimens of Oral Hypoglycaemic Agents in Type 2 Diabetes Mellitus Patients
Endang Kumolosasi
Tropical Journal of Pharmaceutical Research, 2015
View PDFchevron_right
Effect of Glyburide—Metformin Combination Tablet in Patients with Type 2 Diabetes
Nain-Feng Chu
Journal of the Chinese Medical Association, 2007
View PDFchevron_right
Improved glycaemic control with metformin–glibenclamide combined tablet therapy (Glucovance®) in Type 2 diabetic patients inadequately controlled on metformin
Lehert Philippe
Diabetic Medicine, 2002
View PDFchevron_right
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
Arnaud Bastien
The Lancet, 2010
View PDFchevron_right